AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26474358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 175
Study 26474358 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 175
Study 26474358 — intervention group
Group type: COMPARATOR
Intervention: No response at 48 h
Number of subjects: 175
Study 26474358 — intervention group
Group type: COMPARATOR
Intervention: Response at 48 h
Number of subjects: 175
Study 26474358 — intervention group
Group type: COMPARATOR
Intervention: AKI at enrolment
Number of subjects: 175
Study 26474358 — intervention group
Group type: COMPARATOR
Intervention: Pneumonia
Number of subjects: 175
Study 26474358 — intervention group
Group type: COMPARATOR
Intervention: Septic shock
Number of subjects: 175
Study 25135646 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthmatic subjects
Number of subjects: 744
Study 22211737 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide partial pulpotomy (PP)
Number of subjects: 56
Study 22211737 — intervention group
Group type: COMPARATOR
Intervention: Formocresol pulpotomy (FP)
Number of subjects: 56
Study 19639917 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary factors influencing professional development in health research
Number of subjects: 0
Study 19639917 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based practice
Number of subjects: 0
Study 19639917 — intervention group
Group type: EXPERIMENTAL
Intervention: Government concerns
Number of subjects: 0
Study 19639917 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual career researcher considerations
Number of subjects: 0
Study 17581176 — intervention group
Group type: COMPARATOR
Intervention: Canal prepared with a D.T. Light Post #1 drill (control)
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal prepared with a D.T. Light Post #2 drill
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal prepared with a D.T. Light Post #3 drill
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Canal prepared with a Gates Glidden #6 drill
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronal third of the root canal
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical third of the root canal
Number of subjects: 32
Study 17581176 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle third of the root canal
Number of subjects: 32
Study 15279533 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIT
Number of subjects: 110
Study 15279533 — intervention group
Group type: COMPARATOR
Intervention: Standard community-based parenting group (Control)
Number of subjects: 110
Study 15279533 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIT plus individualized enhanced services
Number of subjects: 110
Study 11515616 — intervention group
Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7
Number of subjects: 20
Study 11515616 — intervention group
Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 6
Number of subjects: 20
Study 11515616 — intervention group
Group type: COMPARATOR
Intervention: Haemonetics MCS+
Number of subjects: 20
Study 11515616 — intervention group
Group type: EXPERIMENTAL
Intervention: COBE Spectra Version 4.7 and COBE Spectra Version 6
Number of subjects: 20
Study 11515616 — intervention group
Group type: EXPERIMENTAL
Intervention: All machines
Number of subjects: 20
Study 9760644 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (60% of maximal aerobic power)
Number of subjects: 22
Study 9760644 — intervention group
Group type: COMPARATOR
Intervention: Rest (no exercise)
Number of subjects: 22
Study 8167386 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CyA)
Number of subjects: 23
Study 8167386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 3412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Binedaline (100 mg)
Number of subjects: 12
Study 3412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (50 mg)
Number of subjects: 12
Study 3412049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Binedaline with alcohol (0.8 g/kg)
Number of subjects: 12
Study 3412049 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine with alcohol (0.8 g/kg)
Number of subjects: 12
Study 31978524 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 161
Study 31978524 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 161
Study 31978524 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 161
Study 30777570 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone injection (1 g in two 500 mg doses)
Number of subjects: 45
Study 27815101 — intervention group
Group type: EXPERIMENTAL
Intervention: Device imaging (TCEP)
Number of subjects: 363
Study 27815101 — intervention group
Group type: COMPARATOR
Intervention: Control imaging
Number of subjects: 363
Study 25973434 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine, 2.5 mg oral, twice a day for 14 days after delivery
Number of subjects: 76
Study 25973434 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study 23172272 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic mesenchymal stem cells (MSCs) - 100 × 10⁶ cells/infusion, 4 monthly infusions
Number of subjects: 62
Study 23172272 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 62
Study 20589677 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemical fecal occult blood testing (I-FOBT; OC-Sensor®)
Number of subjects: 4460265
Study 19964884 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-enhanced robot-aided motor training (SERMT)
Number of subjects: 9
Study 19964884 — intervention group
Group type: COMPARATOR
Intervention: Robot-aided motor training only (RMT)
Number of subjects: 9
Study 17711564 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose normal saline (DS)
Number of subjects: 120
Study 17711564 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate (RL)
Number of subjects: 120
Study 15078765 — intervention group
Group type: EXPERIMENTAL
Intervention: PercussiveTech HF (PTHF) device
Number of subjects: 10
Study 15078765 — intervention group
Group type: COMPARATOR
Intervention: Standard manual chest physiotherapy (CPT)
Number of subjects: 10
Study 12594105 — intervention group
Group type: EXPERIMENTAL
Intervention: ASAS improvement criteria (ASAS‐IC)
Number of subjects: 55
Study 12594105 — intervention group
Group type: COMPARATOR
Intervention: Expert panel consensus
Number of subjects: 55
Study 12594105 — intervention group
Group type: EXPERIMENTAL
Intervention: Provisional criteria sets
Number of subjects: 55
Study 12594105 — intervention group
Group type: EXPERIMENTAL
Intervention: All criteria sets and ASAS‐IC
Number of subjects: 55
Study 9612872 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygienic measures (change of toothbrush, bed linen, washing of toys)
Number of subjects: 114
Study 9612872 — intervention group
Group type: COMPARATOR
Intervention: No hygienic measures
Number of subjects: 114
Study 7648682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (30 to 50 mg)
Number of subjects: 16
Study 7648682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg)
Number of subjects: 16
Study 7648682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (80 mg)
Number of subjects: 16
Study 7648682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (any dose)
Number of subjects: 16
Study 2751279 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular recombinant alpha interferon (rIFN-2A; 9 million IU given for 5 days)
Number of subjects: 105
Study 2751279 — intervention group
Group type: COMPARATOR
Intervention: Topical acyclovir
Number of subjects: 105
Study 2751279 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular recombinant alpha interferon (rIFN-2A)
Number of subjects: 105
Study 799566 — intervention group
Group type: EXPERIMENTAL
Intervention: Bethanidine
Number of subjects: 0
Study 799566 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 0
Study 799566 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 799566 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall side effects
Number of subjects: 0
Study 31669298 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation restrictions
Number of subjects: 54
Study 31669298 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with participation
Number of subjects: 54
Study 31669298 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between participation restrictions and satisfaction
Number of subjects: 54
Study 31669298 — intervention group
Group type: EXPERIMENTAL
Intervention: Differences between satisfied and dissatisfied partners
Number of subjects: 54
Study 31893589 — intervention group
Group type: EXPERIMENTAL
Intervention: Densiron® 68
Number of subjects: 23
Study 31893589 — intervention group
Group type: COMPARATOR
Intervention: Oxane® HD
Number of subjects: 23
Study 27901214 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychodynamic psychotherapy (n=90)
Number of subjects: 272
Study 27901214 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine therapy (n=91)
Number of subjects: 272
Study 27901214 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (n=91)
Number of subjects: 272
Study 27901214 — intervention group
Group type: COMPARATOR
Intervention: Long-term psychodynamic psychotherapy
Number of subjects: 272
Study 27901214 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 272
Study 26048346 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic weight‐bearing Assessment of Pain (DAP)
Number of subjects: 20
Study 26048346 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic weight‐bearing Assessment of Pain (DAP) knee bend scores
Number of subjects: 20
Study 22591950 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (200mg)
Number of subjects: 13
Study 22591950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 20605734 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated (V) group
Number of subjects: 72
Study 20605734 — intervention group
Group type: COMPARATOR
Intervention: Non-vaccinated (NV) group
Number of subjects: 72
Study 19409919 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance at 1m (far targets)
Number of subjects: 47
Study 19409919 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance at 0.33m (near targets)
Number of subjects: 47
Study 19409919 — intervention group
Group type: EXPERIMENTAL
Intervention: Target complexity (simple vs. complex)
Number of subjects: 47
Study 17803715 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 micrograms oral misoprostol
Number of subjects: 447
Study 17803715 — intervention group
Group type: COMPARATOR
Intervention: Manual vacuum aspiration (MVA)
Number of subjects: 447
Study 14741670 — intervention group
Group type: COMPARATOR
Intervention: Neutral cue trials
Number of subjects: 0
Study 14741670 — intervention group
Group type: COMPARATOR
Intervention: Valid cue trials
Number of subjects: 0
Study 14741670 — intervention group
Group type: COMPARATOR
Intervention: Invalid cue trials
Number of subjects: 0
Study 11496232 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 525
Study 9579878 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte zinc protoporphyrin (ZPP) measurement combined with mean corpuscular volume (MCV) measurement
Number of subjects: 0
Study 9579878 — intervention group
Group type: COMPARATOR
Intervention: Mean corpuscular volume (MCV) measurement
Number of subjects: 0
Study 7994788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical instillation of epirubicin
Number of subjects: 53
Study 2719235 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 100 mcg
Number of subjects: 55
Study 2719235 — intervention group
Group type: COMPARATOR
Intervention: Epidural pethidine 50 mg
Number of subjects: 55
Study 1015894 — intervention group
Group type: EXPERIMENTAL
Intervention: Payne operation (35 cm of jejunum anastomosed end‐to‐side to 10 cm of ileum)
Number of subjects: 105
Study 1015894 — intervention group
Group type: COMPARATOR
Intervention: Scott operation (30 cm of jejunum anatomosed end‐to‐end to 15 cm of ileum with the proximal cut end of ileum vented into the transverse colon)
Number of subjects: 105
Study 1015894 — intervention group
Group type: EXPERIMENTAL
Intervention: Scott operation with varying lengths of jejunum and ileum
Number of subjects: 105
Study 1015894 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of jejunum
Number of subjects: 105
Study 1015894 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative assessment
Number of subjects: 105
Study 31577546 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage PRF followed by local anesthetics, hyaluronidase, and betamethasone
Number of subjects: 41
Study 31577546 — intervention group
Group type: COMPARATOR
Intervention: Epidural adhesiolysis (EA)
Number of subjects: 41
Study 30691507 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy plus percutaneous coronary intervention (PCI)
Number of subjects: 410
Study 30691507 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 410
Study 30691507 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy plus PCI
Number of subjects: 410
Study 27746061 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat 0.5 mg (up-titrated to a maximum dose of 2.5 mg TID over 10 weeks)
Number of subjects: 0
Study 27746061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27746061 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 0
Study 25212766 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Hazard Modification Program (HHMP)
Number of subjects: 130
Study 25212766 — intervention group
Group type: COMPARATOR
Intervention: Control group (fall prevention multifactorial programs without HHMP)
Number of subjects: 130
Study 23478342 — intervention group
Group type: COMPARATOR
Intervention: Transcranial alternating current stimulation (tACS) at 1.0 mA intensity between 2 to 250 Hz
Number of subjects: 20
Study 21234592 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate (CHO) beverage
Number of subjects: 10
Study 21234592 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) (flavoured water)
Number of subjects: 10
Study 19861694 — intervention group
Group type: EXPERIMENTAL
Intervention: Characterized chondrocyte implantation
Number of subjects: 67
Study 19861694 — intervention group
Group type: COMPARATOR
Intervention: Microfracture
Number of subjects: 67
Study 19861694 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative low-load activities (high levels)
Number of subjects: 67
Study 19861694 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative low-load activities (lack of)
Number of subjects: 67
Study 16969787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Number of subjects: 12
Study 16969787 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation at acupuncture points LI4 and LI11
Number of subjects: 12
Study 16969787 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint stimulation
Number of subjects: 12
Study 16649870 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 188
Study 16649870 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral package
Number of subjects: 188
Study 16649870 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic cognitive‐behavioral package
Number of subjects: 188
Study 16649870 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic analgesia suggestion
Number of subjects: 188
Study 16649870 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 188
Study 16649870 — intervention group
Group type: COMPARATOR
Intervention: No‐treatment control
Number of subjects: 188
Study 14657693 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate and calcium
Number of subjects: 117
Study 14657693 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol and calcium
Number of subjects: 117
Study 10598427 — intervention group
Group type: EXPERIMENTAL
Intervention: Diprifusor TCI (TCI group)
Number of subjects: 160
Study 10598427 — intervention group
Group type: COMPARATOR
Intervention: Manually controlled infusion (MI group)
Number of subjects: 160
Study 8526168 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpare D. pteronyssinus extract, maintenance dose of 10,000‐12,500 BU's
Number of subjects: 49
Study 8526168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 1936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 72
Study 1936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 72
Study 1936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Glibenclamide added to Metformin)
Number of subjects: 72
Study 1936477 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Metformin added to Glibenclamide)
Number of subjects: 72
Study 6757152 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg mepindolol daily
Number of subjects: 138
Study 6757152 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrochlorothiazide daily
Number of subjects: 138
Study 6757152 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg mepindolol plus 12.5 mg hydrochlorothiazide daily
Number of subjects: 138
Study 6757152 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during washout period)
Number of subjects: 138
Study 29540872 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative exercise therapy with Maitland thoracic manipulation
Number of subjects: 40
Study 29540872 — intervention group
Group type: COMPARATOR
Intervention: Conservative exercise therapy alone
Number of subjects: 40
Study 27249161 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based stress management intervention (iSMI)
Number of subjects: 264
Study 27249161 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WLC)
Number of subjects: 264
Study 25564779 — intervention group
Group type: EXPERIMENTAL
Intervention: State Entropy
Number of subjects: 40
Study 25564779 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral Index (BIS)
Number of subjects: 40
Study 25564779 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane/Remifentanil
Number of subjects: 40
Study 25564779 — intervention group
Group type: COMPARATOR
Intervention: Propofol/Remifentanil
Number of subjects: 40
Study 23123376 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 gm at induction followed by 3 oral doses of 500 mg during 24 hours)
Number of subjects: 200
Study 23123376 — intervention group
Group type: COMPARATOR
Intervention: Control (no tranexamic acid)
Number of subjects: 200
Study 20190623 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PVP)
Number of subjects: 49
Study 20190623 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 49
Study 18167405 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecenoate 80 mg twice daily for 6 months
Number of subjects: 237
Study 18167405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 18167405 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecenoate
Number of subjects: 237
Study 17062431 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg)
Number of subjects: 38
Study 17062431 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (40 mg)
Number of subjects: 38
Study 12937992 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° retinotomy and macular translocation
Number of subjects: 30
Study 12937992 — intervention group
Group type: COMPARATOR
Intervention: Fellow eye (control)
Number of subjects: 30
Study 10633486 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amphetamine (30 mg)
Number of subjects: 25
Study 10633486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 9360514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine-rebound method (group 1)
Number of subjects: 162
Study 9360514 — intervention group
Group type: COMPARATOR
Intervention: Long protocol (group 2)
Number of subjects: 162
Study 1394754 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.25 mg.kg‐1
Number of subjects: 14
Study 1394754 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.5 mg.kg‐1
Number of subjects: 14
Study 3915885 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam (20 mg, 30 mg, 40 mg)
Number of subjects: 0
Study 3915885 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam (equivalent once-daily dosage)
Number of subjects: 0
Study 28953494 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 110
Study 28953494 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine
Number of subjects: 110
Study 26027555 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic PMS (0.9 % saline in 5 % dextrose and potassium chloride 20 meq/L)
Number of subjects: 119
Study 26027555 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic PMS (0.18 % saline in 5 % dextrose and potassium chloride 20 meq/L)
Number of subjects: 119
Study 26027555 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic PMS
Number of subjects: 119
Study 25040947 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate polymer film
Number of subjects: 12
Study 25040947 — intervention group
Group type: COMPARATOR
Intervention: Traditional barrier film
Number of subjects: 12
Study 25040947 — intervention group
Group type: COMPARATOR
Intervention: Control sites
Number of subjects: 12
Study 22318052 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 34
Study 22318052 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 34
Study 20156044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 40
Study 20156044 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40